An Artificial Intelligence-Based Federated Learning Platform to Boost Precision Medicine in Rare Hematological Diseases: An Initiative By GenoMed4all and Synthema ConsortiaGianluca Asti, Federico Álvarez, Silke Gloaguen et al.|Blood|2024Cited by 6
Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell DiseaseAnna Collado Gimbert, María del Mar Mañú‐Pereira, Sara Reidel et al.|Blood|2024Cited by 0
Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL ProjectAmira Idrizovic, Minke A.E. Rab, Marissa J.M. Traets et al.|Blood|2024Cited by 0
Novel oxygenscan parameters differentiate unique hemolytic and inflammatory profiles associated with sickle cell disease genotypesAmira Idrizovic, Minke A.E. Rab, Marissa J.M. Traets et al.|Scientific Reports|2026Cited by 0